Agenus Inc. Reveals Promising Liver Cancer Treatment Results at AACR 2025
Agenus Inc. presents promising results from a Phase 1 study on hepatocellular carcinoma, showing durable responses in heavily pretreated patients with its combination therapy of botensilimab and balstilimab.
2 minutes to read